CoChat

Prevalence of Polycystic Ovary Syndrome in Patients With Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis

Cioana, Milena, Deng, Jiawen, Nadarajah, Ajantha, Hou, Maggie, Qiu, Yuan, Chen, Sondra Song Jie, Rivas, Angelica, Banfield, Laura, Alfaraidi, Haifa, Alotaibi, Ahlam, Thabane, Lehana, Samaan, M. Constantine · 2022 · JAMA Network Open
Cited by 52

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamanetworkopen.2021.47454

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 47

  1. Dabelea, 2014, Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009., JAMA, 311, 1778, 10.1001/jama.2014.3201 · DOI · Paper page
  2. Nadeau, 2008, Epidemiology of type 2 diabetes in children and adolescents., Endocr Res, 33, 35, 10.1080/07435800802080138 · DOI · Paper page
  3. Dabelea, 1998, Increasing prevalence of type II diabetes in American Indian children., Diabetologia, 41, 904, 10.1007/s001250051006 · DOI · Paper page
  4. Dabelea, 1999, Type 2 diabetes mellitus in minority children and adolescents: an emerging problem., Endocrinol Metab Clin North Am, 28, 709, 10.1016/S0889-8529(05)70098-0 · DOI · Paper page
  5. Mayer-Davis, 2017, Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012., N Engl J Med, 376, 1419, 10.1056/NEJMoa1610187 · DOI · Paper page
  6. Divers, 2020, Trends in incidence of type 1 and type 2 diabetes among youths: selected counties and Indian reservations, United States, 2002-2015., MMWR Morb Mortal Wkly Rep, 69, 161, 10.15585/mmwr.mm6906a3 · DOI · Paper page
  7. Kim, 2019, Trends in prevalence of cardiovascular risk factors from 2002 to 2012 among youth early in the course of type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study., Pediatr Diabetes, 20, 693
  8. Reynolds, 2018, Mortality in youth-onset type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth study., J Diabetes Complications, 32, 545, 10.1016/j.jdiacomp.2018.03.015 · DOI · Paper page
  9. Cioana, 2021, Prevalence of hypertension and albuminuria in pediatric type 2 diabetes: a systematic review and meta-analysis., JAMA Netw Open, 4, 10.1001/jamanetworkopen.2021.6069 · DOI · Paper page
  10. Christensen, 2013, Prevalence of polycystic ovary syndrome in adolescents., Fertil Steril, 100, 470, 10.1016/j.fertnstert.2013.04.001 · DOI · Paper page
  11. Naz, 2019, The prevalence of polycystic ovary syndrome in adolescents: a systematic review and meta-analysis., Int J Reprod Biomed, 17, 533
  12. Peña, 2020, Adolescent polycystic ovary syndrome according to the international evidence-based guideline., BMC Med, 18, 72, 10.1186/s12916-020-01516-x · DOI · Paper page
  13. Tay, 2020, Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood., BMC Med, 18, 389, 10.1186/s12916-020-01861-x · DOI · Paper page
  14. Baillargeon, 2003, Insulin sensitizers for polycystic ovary syndrome., Clin Obstet Gynecol, 46, 325, 10.1097/00003081-200306000-00011 · DOI · Paper page
  15. Arslanian, 2001, Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease., J Clin Endocrinol Metab, 86, 66
  16. Hudnut-Beumler, 2021, Development of type 2 diabetes in adolescent girls with polycystic ovary syndrome and obesity., Pediatr Diabetes, 22, 699, 10.1111/pedi.v22.5 · doi:10.1111/pedi.v22.5
  17. Çoban, 2019, Psychiatric disorders, self-esteem, and quality of life in adolescents with polycystic ovary syndrome., J Pediatr Adolesc Gynecol, 32, 600, 10.1016/j.jpag.2019.07.008 · DOI
  18. Fazleen, 2018, Risk of metabolic syndrome in adolescents with polycystic ovarian syndrome: a systematic review and meta-analysis., Diabetes Metab Syndr, 12, 1083, 10.1016/j.dsx.2018.03.014 · DOI · Paper page
  19. Sari, 2020, Body perception, self-esteem, and comorbid psychiatric disorders in adolescents diagnosed with polycystic ovary syndrome., J Pediatr Adolesc Gynecol, 33, 691, 10.1016/j.jpag.2020.08.018 · DOI
  20. Balen, 2007, Managing anovulatory infertility and polycystic ovary syndrome., BMJ, 335, 663, 10.1136/bmj.39335.462303.80 · DOI · Paper page
  21. Benson, 2020, Depression in girls with obesity and polycystic ovary syndrome and/or type 2 diabetes., Can J Diabetes, 44, 507, 10.1016/j.jcjd.2020.05.015 · DOI
  22. Dunaif, 1996, Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome., J Clin Endocrinol Metab, 81, 942
  23. Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group., JAMA, 283, 2008, 10.1001/jama.283.15.2008 · DOI · Paper page
  24. Borenstein, 2010, A basic introduction to fixed-effect and random-effects models for meta-analysis., Res Synth Methods, 1, 97, 10.1002/jrsm.12 · DOI · Paper page
  25. Viechtbauer, 2010, Conducting meta-analyses in R with the metafor package., J Stat Softw, 36, 1, 10.18637/jss.v036.i03 · DOI · Paper page
  26. Amed, 2012, Differing clinical features in Aboriginal vs. non-Aboriginal children presenting with type 2 diabetes., Pediatr Diabetes, 13, 470, 10.1111/pedi.2012.13.issue-6 · doi:10.1111/pedi.2012.13.issue-6
  27. Amutha, 2012, Clinical profile and complications of childhood- and adolescent-onset type 2 diabetes seen at a diabetes center in south India., Diabetes Technol Ther, 14, 497, 10.1089/dia.2011.0283 · DOI · Paper page
  28. Balasanthiran, 2012, Type 2 diabetes in children and young adults in East London: an alarmingly high prevalence., Pract Diabetes., 29, 193, 10.1002/pdi.v29.5 · doi:10.1002/pdi.v29.5
  29. Pérez-Perdomo, 2005, Type 2 diabetes mellitus among youth in Puerto Rico, 2003., P R Health Sci J, 24, 111
  30. Zdravkovic, 2004, Presentation and course of type 2 diabetes in youth in a large multi-ethnic city., Diabet Med, 21, 1144, 10.1111/dme.2004.21.issue-10 · doi:10.1111/dme.2004.21.issue-10
  31. Shield, 2009, Management and 1 year outcome for UK children with type 2 diabetes., Arch Dis Child, 94, 206, 10.1136/adc.2008.143313 · DOI · Paper page
  32. Reinehr, 2013, Type 2 diabetes mellitus in children and adolescents., World J Diabetes, 4, 270, 10.4239/wjd.v4.i6.270 · DOI · Paper page
  33. Kaczmarek, 2016, Health-related quality of life in adolescents and young adults with polycystic ovary syndrome: a systematic review., J Pediatr Adolesc Gynecol, 29, 551, 10.1016/j.jpag.2016.05.006 · DOI · Paper page
  34. Sadeeqa, 2018, Polycystic ovarian syndrome-related depression in adolescent girls: a review., J Pharm Bioallied Sci, 10, 55, 10.4103/JPBS.JPBS_1_18 · DOI
  35. Patel, 2017, Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers., Vasc Med, 22, 85, 10.1177/1358863X16682107 · DOI · Paper page
  36. Rosenfield, 2011, Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test., Hum Reprod, 26, 3138, 10.1093/humrep/der291 · DOI · Paper page
  37. Soldani, 1994, Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro., Eur J Endocrinol, 131, 641, 10.1530/eje.0.1310641 · DOI · Paper page
  38. O’Connor, 2010, High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance., J Clin Endocrinol Metab, 95, 1378, 10.1210/jc.2009-1557 · DOI · Paper page
  39. O’Reilly, 2015, Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome., Lancet, 385, S16, 10.1016/S0140-6736(15)60331-2 · DOI
  40. Mai, 2008, Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial., J Clin Endocrinol Metab, 93, 3900, 10.1210/jc.2008-0714 · DOI · Paper page
  41. Bellanger, 2012, Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells., Steroids, 77, 347, 10.1016/j.steroids.2011.12.017 · DOI
  42. Carpentier, 2008, Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes., Diabetes Metab, 34, 97, 10.1016/j.diabet.2007.10.009 · DOI
  43. de Zegher, 2009, Adipose tissue expandability and the early origins of PCOS., Trends Endocrinol Metab, 20, 418, 10.1016/j.tem.2009.06.003 · DOI
  44. Villa, 2011, Adipose tissue dysfunction in polycystic ovary syndrome., Curr Diab Rep, 11, 179, 10.1007/s11892-011-0189-8 · DOI
  45. Shenep, 2017, Characteristics and ethnic variations of adolescents with polycystic ovarian syndrome at a tertiary care center., J Pediatr Endocrinol, 2, 1019
  46. OCEBM Levels of Evidence Working Group. The Oxford 2011 levels of evidence. Oxford Centre for Evidence-Based Medicine. 2011. Accessed January 7, 2022. http://www.cebm.net/index.aspx?o=5653
  47. Deeks? J, Higgins? J, Altman? D, eds. Chapter 10: Analysing data and undertaking meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions. Version 6.0. Cochrane; 2019. Accessed January 5, 2022. https://training.cochrane.org/handbook/archive/v6/chapter-10

Cited by

See all 52

Metadata

Authors
Cioana, M., Deng, J., Nadarajah, A., Hou, M., Qiu, Y., Chen, S. S. J., Rivas, A., Banfield, L., Alfaraidi, H., Alotaibi, A., Thabane, L., & Samaan, M. C.
Venue
JAMA Network Open
Published
2022-02-15
Volume
5
Issue
2
Pages
e2147454
ISSN
2574-3805
Cited by
52
References
22
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.